vimarsana.com

Page 11 - பரந்த நிறுவனம் இல் கேம்பிரிட்ஜ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cancer vaccine helped keep melanoma under control for years in small study

Cancer vaccine helped keep melanoma under control for years in small study Nicoletta Lanese © Provided by Live Science T cells attacking cancer cell A personalized cancer vaccine may help keep a deadly form of skin cancer from growing for years, a small new study in humans suggests. Unlike vaccines that prevent infections, such as measles and influenza, cancer vaccines are a form of immunotherapy that take down cancer cells that already exist. The vaccines train immune cells, called T cells, to better recognize cancer and target it for destruction, while sparing healthy cells in the body.  For example, the new experimental vaccine works by training T cells to spot specific proteins on melanoma cells, a type of skin cancer. In the study, scientists found that the T cells continue to remember these proteins for at least four years after the vaccination and they even learn to recognize more melanoma-related proteins over time.

After a rough start to his tenure, President David Fithian has high ambitions for Clark University

David Fithian could hardly have faced a more challenging first semester starting out his term as president of Clark University. Fithian, a 1987 Clark graduate, was chosen for the job at the Worcester school in January, when he spoke of the importance of listening to the community’s needs and facing bold ideas. Then the coronavirus pandemic hit. Later, the campus was faced with racial equality protests and made headlines when it broke ties with the Worcester Police Department.  Image Clark University President David Fithian For Fithian, the pandemic in particular forced him to quickly form collaborative relationships with presidents of other nearby colleges and form operational plans with a Clark administration he was only just starting to get to know.

Nova Scotian researcher sheds light on Boston COVID-19 superspreader event

Posted: Dec 13, 2020 1:37 PM AT | Last Updated: December 13, 2020 Nova Scotian Bronwyn MacInnis was senior author of a study tracking a COVID-19 superspreading event in Boston(Stephen Schaffner) comments A scientist originally from Nova Scotia was part of a Massachusetts-based team that used genetic fingerprinting to track the devastating spread of COVID-19 from a single event. A Biogen corporate conference held at a Boston hotel in February led to an estimated 245,000 infections in 29 U.S. states and several countries around the world by Nov. 1.  Bronwyn MacInnis, director of pathogen genomic surveillance at the Broad Institute in Cambridge, Mass., led a team that used genetic fingerprinting to track the spread of the virus from the Boston conference. 

Cape Cod COVID-19 tests sites to open next week with sliding-scale fee

Cape Cod Times The barnlike marketplace building that houses commercial vendors during the Barnstable County Fair will have a new life as a coronavirus testing site as early as next week. An additional site is opening up at the Cape Cod Melody Tent in Hyannis next week, to be followed by expanded test sites operated by Outer Cape Health Services at its offices in Wellfleet and Provincetown. While the new sites offer expanded molecular PCR tests for COVID-19, the tests won’t be free for all, state legislators said Tuesday morning. “It’s not a Stop the Spread site,” state Sen. Julian Cyr, D-Truro, said during a press teleconference Tuesday morning. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.